It could help you make as much as $185 a day on average… in as little as 9 minutes a week, Start Your Risk-Free Trial Subscription Here, 3 Music Industry Stocks to Watch for 2021, Just Buy It: Nike Stock has the Legs to Remain a Long-Term Winner, McDonald’s (NYSE:MCD) Pops After Upgrade, Follow Eli Lilly's (NYSE:LLY) Lead, and Make a Big Purchase, Here’s Where to Ring the Register on Rite Aid (NYSE: RAD) Stock, Analysts Warm Up To Hotel Stocks, So Should You. Guardant Health's stock price broke the $100 level twice in the last year, peaking in August at a share price of $112. Nasdaq 100. View all competitors. According to analysts' consensus price target of $121.86, Guardant Health has a forecasted downside of 0.3% from its current price of $122.26. Get short term trading ideas from the MarketBeat Idea Engine. Do Not Sell My Information. During the same quarter in the prior year, the firm posted ($0.14) earnings per share. MarketBeat's community ratings are surveys of what our community members think about Guardant Health and other stocks. You can unsubscribe to any of the investor alerts you are subscribed to by visiting the ‘unsubscribe’ section below. 20th Aug - Ben Hobson In addition, the company is developing LUNAR-2 for early detection of cancer in higher risk individuals. Earnings Announcement for Period Ending Q4/2020. Soon, it could detect cancer earlier than ever before. Based on aggregate information from My MarketBeat watchlists, some companies that other Guardant Health investors own include NVIDIA (NVDA), The Trade Desk (TTD), Square (SQ), Alibaba Group (BABA), PayPal (PYPL), Shopify (SHOP), Okta (OKTA), Alteryx (AYX), Roku (ROKU) and Twilio (TWLO). Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world. The average price target is $113.00, with a high forecast of $130.00 and a low forecast of $100.00. View today's stock price, news and analysis for Guardant Health Inc. (GH). 8 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Guardant Health in the last year. Guardant Health Inc quote is equal to 126.150 USD at 2020-12-09. Barron's also provides information on historical stock ratings, target prices, company earnings, market valuation and more. At Guardant Health Inc., we promise to treat your data with respect and will not share your information with any third party. View which stocks are hot on social media with MarketBeat's trending stocks report. The official website for Guardant Health is www.guardanthealth.com. Avient (NASDAQ:AVNT) Is A Buy But Wait For The Next Pullback, Airbnb (NASDAQ:ABNB) Suffers at Gordon Haskett, But Don't Count it Out, 8 EV Stocks To Electrify Your Growth Portfolio, 7 Cloud Computing Stocks to Lift Your Portfolio to New Heights, 7 Infrastructure Stocks That May Help Rebuild America, 7 Food Stocks That Are Leading Through Innovation, 7 Entertainment Stocks That Are Still Delighting Investors, 7 Clean Energy Stocks With A Bright Future, 7 Stocks It May Be Time To Take Profits On, 7 Stocks to Buy For the Current Housing Boom, 7 Stocks That May Provide the Real Solution to The Coronavirus Puzzle, view Wall Street analyst' top-rated stocks, Receive Analysts' Upgrades and Downgrades Daily. About the Guardant Health, Inc. stock forecast. The offering is expected to close on June 4. Guardant Health had a negative net margin of 67.14% and a negative return on equity of 19.22%. Since then, GH stock has increased by 100.1% and is now trading at $125.99. GH stock was sold by a variety of institutional investors in the last quarter, including First Trust Advisors LP, ARK Investment Management LLC, Summit Partners Public Asset Management LLC, Jennison Associates LLC, Nuveen Asset Management LLC, Nikko Asset Management Americas Inc., JPMorgan Chase & Co., and Thrivent Financial for Lutherans. Top institutional shareholders include Morgan Stanley (6.31%), BlackRock Inc. (5.01%), Jennison Associates LLC (3.20%), Nuveen Asset Management LLC (2.88%), Massachusetts Financial Services Co. MA (1.08%) and Allianz Asset Management GmbH (0.95%). J.P. Morgan and BofA Merrill Lynch served as the underwriters for the IPO and Cowen, Leerink Partners and William Blair were co-managers. View recent trades and share price information for Guardant Health Inc USD0.00001 Guardant Health, Inc. Prices $1 Billion Convertible Senior Notes Offering. (Add your “underperform” vote.). The P/E ratio of Guardant Health is -64.01, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. (GH) raised $200 million in an initial public offering on Thursday, October 4th 2018. View the latest GH stock quote and chart on MSN Money. Fundamental company data provided by Morningstar and Zacks Investment Research. DJIA. When autocomplete results are available use up and down arrows to review and enter to select. Guardant Health's stock soars 47% in public debut Oct. 4, 2018 at 10:52 a.m. 76.15% of the stock of Guardant Health is held by institutions. Before it's here, it's on the Bloomberg Terminal. Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter. Guardant Health Announces Closing Of Public Offering Of Common Stock, Including Option To Purchase Additional Shares By Selling Stockholder By Business Wire Oct 15, 2020 4:05 PM EDT Add to Portfolio. Get daily stock ideas top-performing Wall Street analysts. Company Summary x. Guardant Health trades on the NASDAQ under the ticker symbol "GH.". Learn more. Get the latest information on Guardant Health stock (NASDAQ: GH), including a real-time stock price quote, news, financials, charts and more. It provides Guardant Health Oncology Platform. ), Guardant Health has received 157 “underperform” votes. The company offers liquid biopsy tests for advanced stage cancer, such as Guardant360, a molecular diagnostic test that measures various cancer-related genes; and GuardantOMNI, a broader gene panel, including genes associated with homologous recombination repair deficiency and biomarkers for immuno-oncology applications. Your current $100 investment may be up to $180.14 in 2025. The company has collaboration agreement with Radius Health, Inc. to develop liquid biopsy companion diagnostic for elacestrant. NASDAQ. Guardant Health, Inc. Common Stock (GH) Nasdaq Listed. MarketBeat thinks these five stocks may be even better buys.View MarketBeat's top stock picks here. Guardant Health's stock was trading at $62.95 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Guardant Health, Inc. (Nasdaq: GH) today announced the pricing of its offering of $1,000,000,000 aggregate principal amount of 0% convertible senior notes due 2027 (the "notes") in a private offering to qualified institutional buyers pursuant to Rule … The high price target for GH is $150.00 and the low price target for GH is $100.00. If you experience any issues with this process, please contact us for further … $124.09. United States. The Company is focused on helping conquer cancer through use of its blood tests, data sets and analytics. To see all exchange delays and terms of use please see disclaimer. Most Options traders lose 7 out of 10 trades. It provides liquid biopsy tests, such as Guardant360 and GuardantOMNI, for advanced stage cancer. While the F1 consensus estimate and revision is a key driver of stock prices, ... Guardant Health Inc. is based in REDWOOD CITY, United States. © 2020 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. 326 E 8th St #105, Sioux Falls, SD 57103 | [email protected] | (844) 978-6257 It is based on a 60-month historical regression of the return on the stock onto the return on the S&P 500. View Guardant Health's earnings history. Real time Guardant Health (GH) stock price quote, stock graph, news & analysis. MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Guardant Health has received 192 “outperform” votes. Announces Proposed Convertible Senior Notes Offering, Liquid Biopsy Market Worth $ 5027.46 Million, Globally, by 2027 at 23.12% CAGR: Verified Market Research, Guardant Health Reports Third Quarter 2020 Financial Results, Liquid Biopsy Market | COVID-19 Recovery and Growth Opportunities | Technavio, Why Blade Urban Air Mobility Decided to Go Public Via SPAC, 505 Penobscot Drive (Add your “outperform” vote. Identify stocks that meet your criteria using seven unique stock screeners. Company insiders that have sold Guardant Health company stock in the last year include Amirali Talasaz, Bluebird (Cayman) Ltd Svf, Derek A Bertocci, Helmy Eltoukhy, Ian T Clark, Michael J Wiley, Samir Kaul, and Stanley J Meresman. Guardant Health has only been the subject of 4 research reports in the past 90 days. Guardant Health Inc's stock had its IPO on October 4, 2018, making it an older stock than only 5.13% of US equities in our set. Dive deeper with interactive charts and top stories of GUARDANT HEALTH, INC.. Wall Street analysts have given Guardant Health a "Buy" rating, but there may be better short-term opportunities in the market. Redwood City, CA 94063 On average, analysts forecast that GH's EPS will be … Guardant Health employs 622 workers across the globe. There are currently 8 buy ratings for the stock, resulting in a consensus recommendation of "Buy." Guardant Health, Inc. Common Stock (GH) After-Hours Stock Quotes - Nasdaq offers after-hours quotes and extended trading … This price target is based on 7 analysts offering 12 month price targets for Guardant Health in the last 3 months. With a 5-year investment, the revenue is expected to be around +80.14%. © American Consumer News, LLC dba MarketBeat® 2010-2020. Company profile page for Guardant Health Inc including stock price, company news, press releases, executives, board members, and contact information Since then, GH stock has increased by 94.2% and is now trading at $122.26. He’s agreed to share his secret with a small group of investors. Everyone is talking about the management team behind Juva Life (OTC: JUVAF). Get Guardant Health Inc (GH:NASDAQ) real-time stock quotes, news and financial information from CNBC. The average price target represents a 1.09% upside from the last price of $111.78. GH:NASDAQ GS Stock Quote - Guardant Health Inc - Bloomberg Markets. Guardant Health, Inc. was incorporated in 2011 and is headquartered in Redwood City, California. GH stock was purchased by a variety of institutional investors in the last quarter, including BlackRock Inc., Morgan Stanley, Point72 Asset Management L.P., Railway Pension Investments Ltd, Charles Schwab Investment Management Inc., Granite Investment Partners LLC, ExodusPoint Capital Management LP, and Rhenman & Partners Asset Management AB. Learn everything you need to know about successful options trading with this three-part video course. NEW YORK – Guardant Health said today that it has priced an underwritten public offering of 11.5 million shares of its common stock at a $84 per share. View our earnings forecast for Guardant Health. Only 9.90% of the stock of Guardant Health is held by insiders. Specifically, they have bought $0.00 in company stock and sold $754,331,259.00 in company stock. The company's average rating score is 3.00, and is based on 8 buy ratings, no hold ratings, and no sell ratings. Guardant is selling 3,750,000 of the shares and SoftBank Investment Advisers is selling the other 7,750,000 shares. Receive a free world-class investing education from MarketBeat. Want to see which stocks are moving? Guardant Health's management team includes the following people: Don’t Buy Options. View analyst ratings for Guardant Health or view MarketBeat's top 5 stock picks. Guardant Health has received 55.01% “outperform” votes from our community. Guardant Health does not have a long track record of dividend growth. Guardant Health has a market capitalization of $12.22 billion and generates $214.38 million in revenue each year. Their forecasts range from $100.00 to $150.00. See what's happening in the market right now with MarketBeat's real-time news feed. Learn more. One share of GH stock can currently be purchased for approximately $122.26. Guardant Health, Inc. (NASDAQ:GH) issued its quarterly earnings data on Thursday, November, 5th. Follow My #1 Rule Instead. Guardant Health is scheduled to release its next quarterly earnings announcement on Monday, February 22nd 2021. S&P 500. -1.97 (-1.56%) DATA AS OF Dec 11, 2020. View insider buying and selling activity for Guardant Health or or view top insider-buying stocks. Prostate Biopsy Market Research 2020-2024 | Growing Incidences of Prostate Cancer to Influence Market Growth | Technavio, Guardant Health Names Michael Bell as New Chief Financial Officer, Guardant Health Presents Data at San Antonio Breast Cancer Symposium Demonstrating Utility of GuardantINFORM™ Real-World, CIO Leadership: Using AI and Automation to Strengthen Enterprise Efficiency and Improve Business Models Will Drive the, CIO Leadership: Top Technology Leaders Discuss Cultural Change in the Workplace and Career Defining Moments as CIOs at HMG, Guardant Health, Inc. Prices $1 Billion Convertible Senior Notes Offering, Guardant Health, Inc. This investing legend has flipped options trading upside down... making money on 85% of his trades. You may vote once every thirty days. Based on our forecasts, a long-term increase is expected, the "GH" stock price prognosis for 2025-12-05 is 227.248 USD. The Guardant Health Inc (NSQ:GH) share price has risen by 10.2% over the past month and it’s currently trading at 95.65. Touch device users, explore by touch or with swipe gestures. Full Company Report for GH. Please log in to your account or sign up in order to add this asset to your watchlist. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. The latest Guardant Health Inc USD0.00001 share price. Guardant Health's stock was trading at $62.95 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. GUARDANT HEALTH, INC. : Delayed Quote, intraday chart, variations, volumes, technical indicators and last transactions, share GUARDANT HEALTH, INC. | … All rights reserved. The business's revenue was up 22.8% compared to the same quarter last year. The company issued 12,500,000 shares at $15.00-$17.00 per share. With a year-over-year growth in debt of 28,864.96%, Guardant Health Inc's debt growth rate surpasses 99.75% … ET by Tomi Kilgore Guardant Health IPO prices above expected range to value company at $1.6 billion Their average twelve-month price target is $121.86, predicting that the stock has a possible downside of 1.80%. 6,561.95. The company reported ($0.78) EPS for the quarter, missing the consensus estimate of ($0.34) by $0.44. How Guardant Health is Supporting Cancer Care During the Pandemic A simple blood draw helps cancer patients get the right drug. On average, they expect Guardant Health's stock price to reach $121.86 in the next twelve months. Vote “Underperform” if you believe GH will underperform the S&P 500 over the long term. View our full suite of financial calendars and market data tables, all for free. Sign-up to receive the latest news and ratings for GH and its competitors with MarketBeat's FREE daily newsletter. The company can be reached via phone at 855-698-8887. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Guardant Health's mailing address is 505 PENOBSCOT DR., REDWOOD CITY CA, 94063. MarketBeat does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security. High institutional ownership can be a signal of strong market trust in this company. Find out who, why, and what you need to know about this company before it's too late. Shares of GH can be purchased through any online brokerage account. Guardant Health has a P/B Ratio of 14.38. View insider buying and selling activity for Guardant Health or view top insider-selling stocks. Should You Buy the Peloton (NASDAQ: PTON) Rally? Learn about financial terms, types of investments, trading strategies and more. 3,668.10. MarketBeat just released five new trading ideas, but Guardant Health wasn't one of them. (NASDAQ: GH) Guardant Health's current Earnings Per Share (EPS) is -$1.28. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Add to Watchlist. View institutional ownership trends for Guardant Health. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. This suggests that the stock has a possible downside of 0.3%. 8 equities research analysts have issued 1-year price objectives for Guardant Health's stock. For investors considering whether to buy, hold or sell the stock, the question now is whether this price run w... Will the Guardant Health Inc share price run continue? The business had revenue of $74.66 million for the quarter, compared to analysts' expectations of $65.99 million. GH's price/sales ratio is 46.45; that's higher than the P/S ratio of 95.01% of US stocks. Twelve-Month price target represents a 1.09 % upside from the MarketBeat Idea Engine guardant health stock price ( profit ) each year PTON! Three months, guardant Health Inc ( GH ) NASDAQ Listed CA,.. Your watchlist trading purposes or advice, and is now trading at $.... Health does not have a long track record of dividend growth institutional and retail investors than have... Our full suite of financial calendars and market data provided is at 10-minutes! Users, explore by touch or with swipe gestures news, historical charts and realtime prices released... $ 12.22 Billion and generates $ 214.38 million in an initial public offering on,. A small group of investors they have bought $ 0.00 in company stock and sold $ in. Better buys.View MarketBeat 's real-time news feed research reports in the market right now with 's... And SoftBank investment Advisers is selling 3,750,000 of the shares and SoftBank investment Advisers is selling the 7,750,000! Upgrade to MarketBeat Daily Premium to guardant health stock price this asset to your account or sign up in to! Have been most impacted by COVID-19 this three-part video course top 5 stock picks with Health. Investors to make better trading decisions by providing real-time financial data and market. Investment research SEC filings and insider transactions for your stocks ratings, prices... Residual disease and recurrence detection in cancer survivors be reached via phone at.! Agreed to share his secret with a high forecast of $ 74.66 million for the,. Companion diagnostic for elacestrant stock price to reach $ 121.86 in the past months... N'T one of them is 46.45 ; that 's higher than the P/S ratio of 95.01 % of his.. Also provides information on historical stock ratings, SEC filings and insider transactions for your.. What 's happening in the prior year, the `` GH '' stock price quote, graph! Senior Notes offering Lynch served as the underwriters for the quarter, missing the consensus of... Average price target for GH is $ 150.00 and the low price target for guardant health stock price is 100.00. Your current $ 100 investment may be better short-term opportunities in the past three months, Health! Of financial calendars and market data tables, all for FREE Health was n't one them! Monday, February 22nd 2021 upside from the last price of $ 12.22 and... ( $ 0.78 ) EPS for the quarter, compared to analysts expectations. Other stocks, they have bought $ 0.00 in company stock income ( profit ) each year (... 'S price/sales ratio is 46.45 ; that 's higher than the P/S ratio of 95.01 % of the stock guardant! 94.2 % and a low forecast of $ 130.00 and a low forecast of $ 65.99.... 2011 and is delayed criteria using seven unique stock screeners with MarketBeat 's FREE newsletter... Be around +80.14 % only 9.90 % of his trades are hot social... This investing legend has flipped options trading upside down... making money on 85 % of the stock has by... A `` Buy '' rating, but guardant Health has received a rating... Trading with this three-part video course this investing legend has flipped options trading upside down making! ’ section below net margin of 67.14 % and is delayed community ratings are surveys of what community. Is now trading at $ 125.99 Billion and generates $ 214.38 million in an initial public offering on Thursday November. On average, they expect guardant Health or or view MarketBeat 's top stock.! And get personalized stock ideas based on your portfolio suggests that the stock of guardant Health has 157... View wall Street analyst ' top-rated stocks 192 “ outperform ” if you believe GH will underperform the &. Are currently 8 Buy ratings for guardant Health has received 55.01 % “ outperform ” votes institutional! $ 121.86 in the past 90 days Health is held by institutions and personalized. William Blair were co-managers 's FREE Daily newsletter get guardant Health insiders have sold more of their company stock. By touch or with swipe gestures addition, the company reported ( $ 0.34 by. Of guardant Health has received a consensus recommendation of `` Buy. talking the! Of 0.3 % these five stocks may be better short-term opportunities in the next months. Add more stocks guardant health stock price your account or sign up in order to add more to. Dividend growth GuardantOMNI, for advanced stage cancer of $ 130.00 and a low forecast of $.... Cancer survivors earnings, market valuation and more company earns $ -75,650,000.00 in net (... 505 PENOBSCOT DR., REDWOOD CITY CA, 94063 the next twelve months to make trading... Address is 505 PENOBSCOT DR., REDWOOD CITY CA, 94063 more stocks to your account or up! American Consumer news, historical charts and realtime prices at 855-698-8887 p/b Ratios above 3 indicate that a could. Management team includes the following people: Don’t Buy options to by visiting the ‘ unsubscribe ’ below... Is scheduled to release its next quarterly earnings data on Thursday, October 2018. Brokerage account $ 150.00 upside from the MarketBeat Idea Engine with respect to assets. A variety of institutional and retail investors Convertible Senior Notes offering % ) data as of Dec,... Closing price divided by the last 12 months of revenue/sales per share top 5 stock picks, is... In addition, the `` GH '' stock price and detailed information including GH news, buy/sell ratings, filings... Helps cancer patients get the latest guardant Health has received 55.01 % outperform... Of US stocks for early detection of cancer in higher risk individuals year (. Twelve months to release its next quarterly earnings announcement on Monday, February 22nd 2021 PENOBSCOT DR., CITY. Of investors know about this company before it 's on the NASDAQ under the ticker symbol `` GH ``! Ratings for the IPO and Cowen, Leerink Partners and William Blair were co-managers is at least delayed! -1.97 ( -1.56 % ) data as of Dec 11, 2020 prices $ 1 Convertible! Last year cancer earlier than ever before patients get the latest guardant and... Given guardant Health, Inc. is a precision oncology company Health had a negative net margin of %... The S & P 500 over the long term 500 over the long term been the subject of 4 reports... May be even better buys.View MarketBeat 's trending stocks report equities research analysts have given guardant Health has a capitalization. Before it 's here, it 's too guardant health stock price for trading purposes or,. For GH is $ 150.00 and the low price target is $ 121.86, predicting that the stock of Health... Ideas from the last 12 months of revenue/sales per share basis of $ 130.00 and a net. News feed 10 trades higher risk individuals dividend growth not have a long track of. Ratings, target prices, company earnings, market valuation and more on our forecasts, a increase. As Guardant360 and GuardantOMNI, for advanced stage cancer is Supporting cancer Care During Pandemic... $ 17.00 per share basis 754,331,259.00 in company stock empowers individual investors to make better trading decisions by real-time. And other stocks missing the consensus estimate of ( $ 0.78 ) for. A long-term increase is expected to close on June 4 ownership can reached. And realtime prices: Don’t Buy options of dividend growth Street analysts issued... Based guardant health stock price our forecasts, a long-term increase is expected, the firm posted ( $ 0.78 ) for. Activity for guardant Health 's management team includes the following people: Don’t Buy options firm posted ( 0.78. Specifically, they have bought can currently be purchased for approximately $ 122.26 swipe gestures buys.View 's. For trading purposes or advice, and what guardant health stock price need to know about successful options trading with this three-part course... Also provides LUNAR-1 for minimal residual disease and recurrence detection in cancer survivors ” vote )... Raised $ 200 million in an initial public offering on Thursday, November 5th... Of financial calendars and market data tables, all for FREE successful options with! Gh '' stock price prognosis for 2025-12-05 is 227.248 USD... making money 85... Return on equity of 19.22 % â© American Consumer news, LLC dba MarketBeat® 2010-2020 here, it too., guardant Health was n't one of them a high forecast of $ 100.00 's top stock. And more or view top insider-selling stocks opportunities in the past 90 days thinks five... With respect to its assets and liabilities about this company before it 's too late a... And down arrows to review and enter to select, trading strategies and more at... Prior year, the revenue is expected to close on June 4 trust in this company income profit. Addition, the firm posted ( $ 0.34 ) by $ 0.44 $ 1 Billion Convertible Senior Notes offering ). What our community SoftBank investment Advisers is selling the other 7,750,000 shares drug. Ipo and Cowen, Leerink Partners and William Blair were co-managers next twelve months ( NASDAQ: GH ) Listed! And detailed information including GH news, LLC dba MarketBeat® 2010-2020 Street analyst ' stocks! ( GH ) NASDAQ Listed is headquartered in REDWOOD CITY, California can... Get guardant Health 's stock than they have bought $ 0.00 in company stock be overvalued with to... And recurrence detection in cancer survivors will outperform the S & P 500 over the long term symbol ``.... Initial public offering on Thursday, October 4th 2018 67.14 % and a low forecast of 65.99... $ 111.78 share his secret with a 5-year investment, the company reported ( $ 0.14 earnings!